Traynor Capital Management, Inc. Lexicon Pharmaceuticals, Inc. Transaction History

Traynor Capital Management, Inc.

  • $1.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023
BUY
$1.06 - $2.33 $1,169 - $2,569
1,103 Added 5.3%
21,909 $23,000
Q2 2023

Jul 28, 2023
BUY
$2.15 - $3.49 $3,745 - $6,079
1,742 Added 9.14%
20,806 $47,000
Q1 2023

Apr 21, 2023
BUY
$1.99 - $2.68 $37,937 - $51,091
19,064 New
19,064 $46,000

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Traynor Capital Management, Inc. Portfolio

Follow Traynor Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email